Under the Medicare Drug Price Negotiation Program, the HHS secretary negotiates directly with manufacturers on the prices ...

The global AI In Life science Analytics Market is projected to be valued at USD 1.9 billion in 2024 and reach USD 3.6 billion ...

Federal science agencies announce they will de-emphasize animal testing for safety and efficacy of new drugs. San Diego scientists are already finding ways to emphasize new models of human biology.

Recursion Pharmaceuticals RXRX shares have plunged 21.6% so far in May. This considerable decline in the stock was observed ...

Q1 2025 Earnings Call Transcript May 13, 2025 Lexicon Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is ...

Explore why INmune Bio, Inc. is a speculative Strong Buy for high-risk investors. Click for the upcoming catalysts that make ...

Generated net FUROSCIX® revenue of $11.8 million in the first quarter of 2025 Formally launched FUROSCIX in second approved indication, Chronic Kidney Disease, in April 2025 Autoinjector on track for ...

When TB is preventable and curable then why over 1 . 1 million people died of it worldwide in 2023 (as per the latest WHO ...

The president—easily swayed by gifts—likely just saved this foreign government thousands if not millions of dollars in ...

BlackDoctor.org's latest panel centered on how the 340B Drug Pricing Program is being manipulated in New York.

State Department officials both in Washington and in Gambia have been aggressively pushing for the West African country to ...

Q1 2025 Earnings Conference Call May 15, 2025 4:30 PM ETCompany ParticipantsBryan Giraudo - COO & CFOFaheem Hasnain ...